Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Insights into US public biotech sector using patenting trends

A Corrigendum to this article was published on 01 August 2006

Analyzing patent data from 1995–2005 show the increasing importance of patenting by small and medium-sized biotech companies.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2: The patent pie is getting bigger but the slices are getting smaller: patent shares in 1995 and 2005.
Figure 3
Figure 4: Patenting trends within the large biotech sector from 1995 to 2005.
Figure 5: Patent trends within the medium-sized biotech companies from 1995 to 2005.
Figure 6: Patent trends within small biotech companies from 1995 to 2005.

References

  1. Mowery, D.C., Nelson, R.R., Sampat, B.N. & Ziedonis, A.A. The growth of patenting and licensing by US universities: an assessment of the effects of the Bayh-Dole act of 1980. Res. Policy 30, 99–119 (2001).

    Article  Google Scholar 

  2. Mehta, S. The emerging role of academia in commercializing innovation. Nat. Biotechnol. 22, 21–24 (2004).

    Article  CAS  Google Scholar 

  3. Mowery, D.C. & Ziedonis, A.A. Academic patent quality and quantity before and after the Bayh-Dole act in the United States. Res. Policy 31, 399–418 (2002).

    Article  Google Scholar 

  4. Kennedy, D. Bayh-Dole: almost 25. Science 307, 1375 (2005).

    Article  CAS  Google Scholar 

  5. Lengauer, C., Diaz, L.A. & Saha, S. Cancer drug discovery through collaboration. Nat. Rev. Drug Disc. 4, 375–380 (2005).

    Article  CAS  Google Scholar 

  6. http://www.uspto.gov/patft/index.html

  7. Lähteenmäki, R. & Baker, M. Public biotechnology 2004—the numbers. Nat. Biotechnol. 22, 665–675 (2004).

    Article  Google Scholar 

  8. http://www.sec.gov/

  9. http://dbic.datamonitor.com/

  10. http://www.lexisnexis.com/

  11. http://www.proquest.com/

  12. http://www.hoovers.com/

  13. Lawrence, S. Biotech patenting matures. Nat. Biotechnol. 22, 1202 (2004).

    Article  CAS  Google Scholar 

  14. Lähteenmäki, R. & Lawrence, S. Public biotechnology 2004—the numbers. Nat. Biotechnol. 23, 663–671 (2005).

    Article  Google Scholar 

  15. Featherstone, J. & Renfrey, S. The licensing gamble: raising the stakes. Nat. Rev. Drug Discov. 3, 107–108 (2004).

    Article  CAS  Google Scholar 

  16. Walsh, J.P., Cho, C. & Cohen, W.M. View from the bench: patents and material transfers. Science 309, 2002–2003 (2005).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Louis P. Galambos, Ozlem Topaloglu and Samuel R. Denmeade for helpful discussions. S.A. would also like to thank The Johns Hopkins University Libraries for providing access to the online news and article databases. Network Appliance has no relation to or intellectual interest in the contents of this study or the designed software.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aggarwal, S., Gupta, V. & Bagchi-Sen, S. Insights into US public biotech sector using patenting trends. Nat Biotechnol 24, 643–651 (2006). https://doi.org/10.1038/nbt0606-643

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0606-643

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing